6f4ff69ad3738955891cee.pdf



PRESS RELEASE

For immediate release


ASX ANNOUNCEMENT


JANGHO FINALISES TAKEOVER BID FOR VISION



(Thursday, 22 October 2015) - Jangho Group Co., Ltd. (Jangho) refers to


he unconditional off-

market takeover bid for all of the ordinary voting shares in Vision Eye Institute Limited (Offer and Vision respectively), made by Jangho's wholly owned Australian subsidiary, Jangho Health Care Australia Pty Ltd (Bidder).


The Bidder advises that the Offer closed at 7.00pm (Melbourne time) on Wednesday, 21 October 2015, with final acceptances taking Jangho interest in Vision ordinary voting shares to approximately 97.49%.


Accordingly, the Bidder will now proceed to compulsorily acquire all of the outstanding ordinary voting shares in Vision in accordance with Part 6A.1 of the Corporations Act 2001 (Cth). The Bidder expects to commence the compulsory acquisition process as soon as possible following completion of the transfer of Vision ordinary voting shares held by accepting shareholders under the Offer.


Holders of Vision ordinary voting shares who have not accepted the Offer will receive notice from the Bidder shortly advising on details of the compulsory acquisition process.


********************************


About Jangho


Jangho is listed on the Main Board A of the Shanghai Stock Exchange (Stock Code: 601886).

Jangho was established in multinational enterprise of

1999. Headquartered in Beijing, Jangho Group is a large-scale facade solutions which integrates R&D, engineering and design

expertise, precision manufacturing, installation, consultancy, and product export for domestic and foreign markets. Jangho is in the top 500 Public Listed Enterprise and the top 500 Private Owned Enterprise in China. Jangho is actively participating in exploring new industries with focus on online business platforms, medical and health as well as PPP projects.

About Vision


Vision is Australia's largest provider of ophthalmic care, diagnosing and treating people with eye disorders and diseases. Vision provides services to doctor partners, associates, and visiting surgeons, offering a broad range of services including specialist eye care in the areas of corneal surgery, refractive surgery, cataract surgery, ocular plastics, glaucoma treatment and surgery, vitreo-retinal surgery, and treatment for macular degeneration. Vision is a public company listed on the Australian Securities Exchange (ASX Code: VEI).

****************************



ME_125762450_1 (W2007)

distributed by